Smurfit Westrock (NYSE: SW) Q2 profit improves while first-half earnings drop
Smurfit Westrock plc reported Q2 2026 net sales of $8,031 million, slightly above $7,940 million a year earlier, driven mainly by favorable foreign exchange partly offset by weaker price/mix. Net income attributable to common shareholders was $89 million (basic and diluted EPS $0.17), versus a $28 million loss in Q2 2025, helped by lower impairment and restructuring charges and lower raw material costs, partly offset by higher freight, depreciation and energy expenses.
For the first half of 2026, net sales were $15,743 million compared with $15,596 million in 2025, while net income attributable to common shareholders declined to $154 million from $356 million as higher freight, depreciation, downtime, energy and weather-related costs outweighed lower raw material and impairment charges and reduced integration costs. Operating cash flow was $969 million, down from $1,064 million, and capital expenditures rose to $1,089 million. Total debt was $14,164 million and shareholders’ equity $18,036 million, with North America Adjusted EBITDA lower and Europe, MEA and APAC higher year over year.
Positive
- Q2 2026 returned to profitability, with net income attributable to common shareholders of $89 million versus a $28 million loss in Q2 2025, supported by lower impairment and restructuring charges.
- Operating cash flow in the first half of 2026 remained strong at $969 million, funding an elevated capital expenditure program of $1,089 million while the company continued paying dividends.
Negative
- Year-to-date net income attributable to common shareholders fell to $154 million from $356 million a year earlier, as higher freight, depreciation, downtime, energy and adverse weather costs outweighed modest sales growth.
- North America segment Adjusted EBITDA declined to $1,301 million in the first half of 2026 from $1,537 million, reflecting higher costs and lower volumes despite favorable currency effects.
Filing Explained
The quarter extends key borrowing maturities, cuts one receivables facility’s size, and declares a September dividend; tax and arbitration matters remain unresolved.
A Form 10-Q is an unaudited interim report. This filing is current through
In June 2026, the company extended its
The revolver had no amounts drawn at
On
A further watch item is the Venezuela arbitration award: an annulment hearing occurred in
Key Figures
Key Terms
Adjusted EBITDA financial
receivables securitization facilities financial
accounts receivable monetization agreements financial
Variable Interest Entities financial
supplier finance programs financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How did Smurfit Westrock (SW) perform in Q2 2026?
What were Smurfit Westrock’s year-to-date 2026 results (SW)?
How did Smurfit Westrock’s segments perform in early 2026 (SW)?
What were Smurfit Westrock’s cash flow and capital spending in H1 2026 (SW)?
What is Smurfit Westrock’s debt position as of June 30, 2026 (SW)?
What dividends has Smurfit Westrock paid or approved in 2026 (SW)?
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
☒ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | |
Emerging growth company | |||
Page | ||
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | 3 | |
PART I | FINANCIAL INFORMATION | 5 |
Item 1. | Financial Statements | 5 |
Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2026 and June 30, 2025 | 5 | |
Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2026 and June 30, 2025 | 6 | |
Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025 | 7 | |
Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2026 and June 30, 2025 | 8 | |
Condensed Consolidated Statements of Changes in Equity for the three and six months ended June 30, 2026 and June 30, 2025 | 9 | |
Notes to Condensed Consolidated Financial Statements | 12 | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 31 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 42 |
Item 4. | Controls and Procedures | 43 |
PART II | OTHER INFORMATION | 44 |
Item 1. | Legal Proceedings | 44 |
Item 1A. | Risk Factors | 44 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 44 |
Item 3. | Defaults Upon Senior Securities | 44 |
Item 4. | Mine Safety Disclosures | 44 |
Item 5. | Other Information | 44 |
Item 6. | Exhibits | 45 |
Signatures | 47 |
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net sales | $ | $ | $ | $ | |||
Cost of goods sold | ( | ( | ( | ( | |||
Gross profit | |||||||
Selling, general and administrative expenses | ( | ( | ( | ( | |||
Impairment and restructuring costs | ( | ( | ( | ( | |||
Transaction and integration-related expenses associated with the Combination | ( | ( | ( | ( | |||
Operating profit | |||||||
Interest expense, net | ( | ( | ( | ( | |||
Pension and other postretirement non-service income, net | |||||||
Other expense, net | ( | ( | ( | ( | |||
Income before income taxes | |||||||
Income tax expense | ( | ( | ( | ( | |||
Net income (loss) | ( | ||||||
Net loss (income) attributable to noncontrolling interests | ( | ||||||
Net income (loss) attributable to common shareholders | $ | $( | $ | $ | |||
Basic earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
Diluted earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net income (loss) | $ | $( | $ | $ | |||
Other comprehensive income, net of tax: | |||||||
Foreign currency translation gain | |||||||
Defined benefit pension and other postretirement benefit plans | ( | ( | |||||
Net loss on cash flow hedges | ( | ( | ( | ||||
Other comprehensive income, net of tax | |||||||
Comprehensive income | |||||||
Comprehensive loss (income) attributable to noncontrolling interests | ( | ||||||
Comprehensive income attributable to common shareholders | $ | $ | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
June 30, 2026 | December 31, 2025 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued expenses | |||
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 14) | |||
Equity: | |||
Preferred stock, $ | |||
Common stock, $ shares outstanding at June 30, 2026 and December 31, 2025, respectively | |||
Treasury stock, at cost; 2025, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Six months ended June 30, | |||
2026 | 2025 | ||
Operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||
Depreciation, depletion and amortization | |||
Impairment of assets | |||
Cash surrender value increase in excess of premiums paid | ( | ( | |
Share-based compensation expense | |||
Deferred income tax benefit | ( | ( | |
Pension and other postretirement funding more than cost | ( | ( | |
Other | ( | ||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||
Accounts receivable | ( | ( | |
Inventories | ( | ||
Other assets | ( | ||
Accounts payable | ( | ||
Income taxes | ( | ||
Accrued liabilities and other | ( | ( | |
Net cash provided by operating activities | |||
Investing activities: | |||
Capital expenditures | ( | ( | |
Cash paid for purchase of businesses, net of cash acquired | ( | ( | |
Proceeds from corporate owned life insurance | |||
Proceeds from sale of property, plant and equipment | |||
Other | |||
Net cash used for investing activities | ( | ( | |
Financing activities: | |||
Additions to debt | |||
Repayments of debt | ( | ( | |
Debt issuance costs | ( | ( | |
Changes in commercial paper, net | ( | ||
Other debt additions (repayments), net | ( | ||
Repayments of finance lease liabilities | ( | ( | |
Proceeds from re-issuance of shares from treasury stock | |||
Tax paid in connection with shares withheld from employees | ( | ( | |
Cash dividends paid to shareholders | ( | ( | |
Other | |||
Net cash used for financing activities | ( | ( | |
Effect of exchange rate changes on cash and cash equivalents | |||
Decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at beginning of period | |||
Cash and cash equivalents at end of period | $ | $ | |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total | |
Balance at March 31, 2026 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | ( | — | ( | — | ( | |
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at June 30, 2026 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total | |
Balance at March 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net loss | — | — | — | — | ( | — | ( | ( | |
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | — | ( | — | ( | — | ( |
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at June 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total | |
Balance at December 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust, net of tax paid in connection with shares withheld from employees | — | — | ( | ( | — | ( | — | ( | |
Re-issuance of shares by Smurfit Kappa Employee Trust | — | — | — | — | — | ||||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of shares held in treasury stock by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at June 30, 2026 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total | |
Balance at December 31, 2024 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | — | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of shares held in treasury stock by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at June 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Three months ended June 30, 2026 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Three months ended June 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Six months ended June 30, 2026 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Six months ended June 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Six months ended June 30, | |||
2026 | 2025 | ||
Capital expenditures: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total per reportable segments | $ | $ | |
Corporate | |||
Total capital expenditures | $ | $ | |
Three months ended June 30, 2026 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended June 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Six months ended June 30, 2026 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Six months ended June 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Impairment charges | $ | $ | $ | $ | |||
Restructuring costs | |||||||
Impairment and restructuring costs | $ | $ | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Impairment of property, plant and equipment | $ | $ | $ | $ | |||
Impairment of other assets | |||||||
Total impairment charges | $ | $ | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
North America | $ | $ | $ | $ | |||
Europe, MEA and APAC | |||||||
Total impairment charges recognized for property, plant and equipment | $ | $ | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
North America | $ | $ | $ | $ | |||
Europe, MEA and APAC | |||||||
LATAM | ( | ( | |||||
Total restructuring costs | $ | $ | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Severance charges | $ | $ | $ | $ | |||
Other costs | |||||||
Total restructuring costs | $ | $ | $ | $ | |||
June 30, | December 31, | ||
2026 | 2025 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable | $ | $ |
June 30, | December 31, | ||
2026 | 2025 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ |
June 30, | December 31, | ||
2026 | 2025 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction-in-progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and impairment | ( | ( | |
Property, plant and equipment, net, excluding forestlands | |||
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ |
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Interest expense | $( | $( | $( | $( | |||
Interest income | |||||||
Interest expense, net | $( | $( | $( | $( | |||
June 30, 2026 | December 31, 2025 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ | |||
Six months ended June 30, | |||
2026 | 2025 | ||
Receivable from financial institutions at January 1 | $ | $ | |
Receivables sold to the financial institutions and derecognized | ( | ( | |
Receivables collected by financial institutions | |||
Cash payments to financial institutions | ( | ( | |
Receivable from financial institutions at June 30 | $ | $ | |
June 30, | December 31, | ||
2026 | 2025 | ||
$ | $ | $ | |
$ | |||
$ | |||
€ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
€ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
Commercial paper | |||
Vendor financing and commercial card programs | |||
Farm credit facility | |||
Other bank loans | |||
Finance lease obligations | |||
Total debt, excluding fair value adjustments, bond discounts and debt issuance costs | |||
Unamortized fair value adjustments, bond discounts and debt issuance costs | ( | ( | |
Total debt | |||
Less: Current portion of debt | ( | ( | |
Non-current debt due after one year | $ | $ |
Defined Benefit Pension Plans | |||||||||||||||
U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | ||||||||||||
Three months ended June 30, | Six months ended June 30, | ||||||||||||||
2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | ||||||||
Service cost | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Interest cost | |||||||||||||||
Expected return on assets | ( | ( | ( | ( | ( | ( | ( | ( | |||||||
Amortization of: | |||||||||||||||
Net actuarial loss | |||||||||||||||
Prior service credit | ( | ||||||||||||||
Curtailment gain | ( | ( | |||||||||||||
Settlement loss | |||||||||||||||
Net periodic benefit (income) cost | $( | $( | $ | $ | $( | $( | $ | $ | |||||||
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Numerator: | |||||||
Net income (loss) attributable to common shareholders | $ | $( | $ | $ | |||
Denominator: | |||||||
Basic weighted average shares outstanding | |||||||
Effect of dilutive share options | |||||||
Diluted weighted average shares outstanding | |||||||
Basic earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
Diluted earnings (loss) per share attributable to common shareholders | $ | $( | $ | $ | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Performance stock units | |||||||
Restricted stock units | |||||||
Total antidilutive shares | |||||||
June 30, | December 31, | ||
2026 | 2025 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable | |||
Inventories | |||
Other current assets | |||
Non-current assets: | |||
Property, plant and equipment, net | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Current portion of debt | |||
Other current liabilities | |||
Non-current liabilities: | |||
Non-current debt due after one year | |||
Other non-current liabilities | |||
Total liabilities | $ | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Adjustments(1) | Total(2) | |
Balance at March 31, 2025 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at June 30, 2025 | $ | $ | $ | $( | $ |
Balance at March 31, 2026 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | ( | ||
Balance at June 30, 2026 | $ | $ | $ | $( | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Adjustments(1) | Total(2) | |
Balance at December 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at June 30, 2025 | $ | $ | $ | $( | $ |
Balance at December 31, 2025 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | ( | ||
Balance at June 30, 2026 | $ | $ | $ | $( | $ |
Three months ended June 30, | |||||||
2026 | 2025 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation gain | $ | $ | $ | $ | $ | $ | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Net actuarial gain (loss) arising during the period | ( | ( | ( | ||||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Prior service cost arising during period | ( | ( | |||||
Foreign currency loss - pensions | ( | ( | ( | ( | |||
Changes in fair value of cash flow hedges | ( | ( | ( | ( | |||
Consolidated other comprehensive income | ( | ||||||
Other comprehensive income attributable to noncontrolling interests | |||||||
Other comprehensive income attributable to common shareholders | $ | $( | $ | $ | $ | $ | |
Six months ended June 30, | |||||||
2026 | 2025 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation gain | $ | $ | $ | $ | $ | $ | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Net actuarial gain (loss) arising during the period | ( | ( | ( | ||||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Prior service cost arising during period | ( | ( | |||||
Amortization of prior service credit | ( | ( | |||||
Foreign currency gain (loss) - pensions | ( | ( | |||||
Changes in fair value of cash flow hedges | ( | ( | |||||
Consolidated other comprehensive income | ( | ||||||
Other comprehensive income attributable to noncontrolling interests | |||||||
Other comprehensive income attributable to common shareholders | $ | $( | $ | $ | $ | $ | |
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net sales | $8,031 | $7,940 | $15,743 | $15,596 | |||
Cost of goods sold | (6,632) | (6,425) | (13,076) | (12,504) | |||
Gross profit | 1,399 | 1,515 | 2,667 | 3,092 | |||
Selling, general and administrative expenses | (970) | (963) | (1,931) | (1,936) | |||
Impairment and restructuring costs | (119) | (280) | (173) | (295) | |||
Transaction and integration-related expenses associated with the Combination | (1) | (21) | (1) | (57) | |||
Operating profit | 309 | 251 | 562 | 804 | |||
Interest expense, net | (179) | (182) | (345) | (349) | |||
Pension and other postretirement non-service income, net | 10 | 7 | 18 | 16 | |||
Other expense, net | (12) | (18) | (23) | (23) | |||
Income before income taxes | 128 | 58 | 212 | 448 | |||
Income tax expense | (40) | (84) | (61) | (92) | |||
Net income (loss) | 88 | (26) | 151 | 356 | |||
Net loss (income) attributable to noncontrolling interests | 1 | (2) | 3 | — | |||
Net income (loss) attributable to common shareholders | $89 | $(28) | $154 | $356 | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net sales (aggregate):(1) | |||||||
North America | $4,743 | $4,755 | $9,245 | $9,424 | |||
Europe, MEA and APAC | 2,826 | 2,778 | 5,597 | 5,360 | |||
LATAM | 559 | 518 | 1,099 | 1,031 | |||
Segment Adjusted EBITDA: | |||||||
North America | $704 | $752 | $1,301 | $1,537 | |||
Europe, MEA and APAC | 380 | 372 | 801 | 761 | |||
LATAM | 124 | 123 | 233 | 238 | |||
Six months ended June 30, | |||
2026 | 2025 | ||
Net cash provided by operating activities | $969 | $1,064 | |
Net cash used for investing activities | $(1,075) | $(996) | |
Net cash used for financing activities | $(109) | $(204) | |
Three months ended June 30, | Six months ended June 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net income (loss) | $88 | $(26) | $151 | $356 | |||
Income tax expense | 40 | 84 | 61 | 92 | |||
Depreciation, depletion and amortization | 678 | 613 | 1,406 | 1,216 | |||
Impairment and restructuring costs | 119 | 280 | 173 | 295 | |||
Transaction and integration-related expenses associated with the Combination | 1 | 21 | 1 | 57 | |||
Interest expense, net | 179 | 182 | 345 | 349 | |||
Pension and other postretirement non-service income, net | (10) | (7) | (18) | (16) | |||
Share-based compensation expense | 27 | 36 | 55 | 79 | |||
Other expense, net | 12 | 18 | 23 | 23 | |||
Other adjustments | 6 | 12 | 19 | 14 | |||
Adjusted EBITDA | $1,140 | $1,213 | $2,216 | $2,465 | |||
SUMMARIZED STATEMENT OF OPERATIONS | Six months ended June 30, |
2026 | |
Net sales to unrelated parties | $730 |
Net sales to Non-Obligor Subsidiaries | 631 |
Gross profit | 365 |
Interest expense, net with unrelated parties | (307) |
Interest expense, net with Non-Obligor Subsidiaries | (166) |
Net income and net income attributable to the Obligor Group | 2,211 |
SUMMARIZED BALANCE SHEETS | June 30, 2026 | December 31, 2025 | |
ASSETS | |||
Current amounts due from Non-Obligor Subsidiaries | $4,648 | $4,571 | |
Other current assets | 703 | 1,207 | |
Total current assets | $5,351 | $5,778 | |
Non-current amounts due from Non-Obligor Subsidiaries | $3,243 | $3,355 | |
Other non-current assets | 943 | 918 | |
Total non-current assets | $4,186 | $4,273 | |
LIABILITIES | |||
Current amounts due to Non-Obligor Subsidiaries | $7,008 | $9,130 | |
Other current liabilities | 1,081 | 482 | |
Total current liabilities | $8,089 | $9,612 | |
Non-current amounts due to Non-Obligor Subsidiaries | $7,135 | $7,447 | |
Other non-current liabilities | 11,652 | 11,823 | |
Total non-current liabilities | $18,787 | $19,270 |
Exhibit Number | Description of Exhibit | ||
3.1 | Amended Constitution of Smurfit Westrock plc (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on July 8, 2024). | ||
10.1† | Amendment No. 6, dated as of June 18, 2026, to Eighth Amended and Restated Credit and Security Agreement, dated as of July 22, 2016, among Smurfit Westrock plc, various Smurfit Westrock plc subsidiaries, and Coöperatieve Rabobank, U.A. | ||
10.2†# | Amended and Restated Offer Letter between Smurfit Westrock and Ben Garren, dated July 29, 2026. | ||
22 | List of Guarantor Subsidiaries and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22 of the Company’s Annual Report on Form 10-K filed on February 27, 2026). | ||
31.1† | Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2† | Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32†* | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.** | ||
101.SCH | Inline XBRL Taxonomy Extension Schema.** | ||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase.** | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Document.** | ||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase.** | ||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase.** | ||
104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Smurfit Westrock plc | ||
Dated: July 31, 2026 | /s/ Anthony Smurfit | |
Name: | Anthony Smurfit | |
Title: | President & Chief Executive Officer | |
(Principal Executive Officer) | ||
Smurfit Westrock plc | ||
Dated: July 31, 2026 | /s/ Ken Bowles | |
Name: | Ken Bowles | |
Title: | Executive Vice President & Chief Financial Officer | |
(Principal Financial Officer) | ||